AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Nabi Changes Name to Nabi Biopharmaceuticals.(Brief Article)

Vaccine Weekly

| May 15, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Nabi (NABI) announced that it has changed its name to Nabi Biopharmaceuticals. This change recognizes the completion of the company's strategic transition to become a vertically integrated biopharmaceutical company.

The company's focus is on the development and commercialization of novel vaccines and antibody based therapies to treat and prevent infectious, autoimmune, and addictive diseases.

"In 2001, we completed the sale of the majority of our antibody business, which provided us with both the financial resources and ability to focus fully on the advancement of our innovative product pipeline," said David J. Gury, chairman, president, and chief executive officer. "We also received FDA ...

Related articles from newspapers, magazines, journals, and more
Nabi Biopharmaceuticals Licenses Its Staphylococcus aureus Whole Cell Vaccine...
Press release article from: PR Newswire April 14, 2003 700+ words
Nabi Biopharmaceuticals today announced...treatment of Staphylococcus aureus infections...agreement covers Nabi Biopharmaceuticals' patent...veterinary Staphylococcus aureus vaccine...such as Staphylococcus aureus and hepatitis...addiction. Nabi ...
Nabi Biopharmaceuticals receives patent for animal vaccine.(Staphylococcus...
Newspaper article from: BIOTECH Patent News March 1, 2003 700+ words
Nabi Biopharmaceuticals (Boca Raton...entitled "Staphylococcus aureus antigen...preliminary study, Nabi Biopharmaceuticals has demonstrated...clear chronic Staphylococcus aureus intramammary...such as Staphylococcus aureus and hepatitis...addiction. ...
Nabi Biopharmaceuticals Receives Second U.S. Patent Covering Staphylococcus...
Press release article from: PR Newswire March 27, 2003 700+ words
Nabi Biopharmaceuticals today announced...entitled "Staphylococcus aureus antigen...preliminary study, Nabi Biopharmaceuticals has demonstrated...clear chronic Staphylococcus aureus intramammary...such as Staphylococcus aureus and hepatitis...addiction. ...
Nabi files MAA for StaphVAX.(Nabi Biopharmaceuticals)(Marketing Authorization...
Newspaper article from: Pharma Marketletter January 3, 2005 700+ words
The USA's Nabi Biopharmaceuticals has submitted a Marketing...seeking approval for StaphVAX (Staphylococcus aureus polysaccharide conjugate...to license submission by Nabi Biopharmaceuticals," he noted.
Nabi Biopharmaceuticals to Present at Cambrex Corporation Annual Analyst...
Press release article from: PR Newswire May 5, 2004 700+ words
Nabi Biopharmaceuticals announced today that...a brief summary of Nabi Biopharmaceuticals' StaphVAX(R) (Staphylococcus aureus Polysaccharide Conjugate...cambrex.com/. About Nabi Biopharmaceuticals Nabi Biopharmaceuticals...
Staph aureus Blood Stream Infection in End Stage Kidney Disease Associated With...
Press release article from: PR Newswire September 17, 2003 700+ words
...sponsored by Nabi Biopharmaceuticals, Inc. and executed...Ph.D., Nabi Biopharmaceuticals senior vice president...approach such as Nabi Biopharmaceuticals' StaphVAX(R) (Staphylococcus aureus Polysaccharide...
Nabi Biopharmaceuticals' StaphVAX(R) Receives Fast Track Designation in the...
Press release article from: PR Newswire October 12, 2004 700+ words
Nabi Biopharmaceuticals announced...StaphVAX(R) [Staphylococcus aureus Polysaccharide...prevention of Staphylococcus aureus (S. aureus...treatment. Nabi Biopharmaceuticals' novel vaccine...related to Staphylococcus aureus bloodstream...affairs, Nabi ...
Nabi Biopharmaceuticals Receives Favorable Opinion From the Committee on Orphan...
Press release article from: PR Newswire Europe September 22, 2005 700+ words
...PRNewswire/ -- Nabi Biopharmaceuticals (Nasdaq...human Staphylococcus aureus immunoglobulin...treatment of Staphylococcus aureus bacteremia...opinion, Nabi Biopharmaceuticals expects to...StaphVAX(R) [Staphylococcus aureus Polysaccharide...Vaccine], ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA